Hypoactive sexual desire disorder (HSDD) is not “female erectile dysfunction (ED)”: challenges with the characterization of HSDD in women based on a systematic literature review

References

• Rosen RC. Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep. 2000;2(3):189–195.
   PubMedGoogle Scholar
• McCabe MP, Sharlip ID, Lewis R, et al. Incidence and prevalence of sexual dysfunction in women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med. 2016;13(2):144–152.
   PubMed Web of Science ®Google Scholar
• Simons JS, Carey MP. Prevalence of sexual dysfunctions: results from a decade of research. Arch Sex Behav. 2001;30(2):177–219.
   PubMed Web of Science ®Google Scholar
• Goldstein I, Kim NN, Clayton AH, et al. Hypoactive sexual desire disorder: International Society for the Study of Women’s Sexual Health (ISSWSH) Expert Consensus Panel Review. Mayo Clin Proc. 2017;92(1):114–128.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association and American Psychiatric Association Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. (4th ed). Washington, DC: American Psychiatric Association; 2000.
   Google Scholar
• Abdolrasulnia M, Shewchuk RM, Roepke N, et al. Management of female sexual problems: perceived barriers, practice patterns, and confidence among primary care physicians and gynecologists. J Sex Med. 2010;7(7):2499–2508.
   PubMed Web of Science ®Google Scholar
• Shifren JL, Monz BU, Russo PA, et al. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008;112(5):970–978.
   PubMed Web of Science ®Google Scholar
• Parish SJ, Hahn SR. Hypoactive sexual desire disorder: a review of epidemiology, biopsychology, diagnosis, and treatment. Sex Med Rev. 2016;4(2):103–120.
   PubMedGoogle Scholar
• US Food and Drug Administration. Low Sexual Interest, Desire, and/or Arousal in Women: Developing Drugs for Treatment [Internet]. 2016 [cited 2018 Nov 15]. Available from: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM526362.pdf
   Google Scholar
• Kingsberg S. Satisfying sexual events (SSEs): a less than satisfying endpoint to determine severity of HSDD. J Sex Med. 2014;11(Suppl 4):219.
   Google Scholar
• American Psychiatric Association and American Psychiatric Association DSM-5 Task Force. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. (5th ed). Washington, DC: American Psychiatric Association; 2013.
   Google Scholar
• Balon R, Clayton AH. Female sexual interest/arousal disorder: a diagnosis out of thin air. Arch Sex Behav. 2014;43(7):1227–1229.
   PubMed Web of Science ®Google Scholar
• World Health Organization. International statistical classification of diseases and related health problems. 10th revision, 2nd ed. Geneva: World Health Organization; 2011.
   Google Scholar
• World Health Organization. International statistical classification of diseases and related health problems. 11th revision. Geneva: World Health Organization; 2018.
   Google Scholar
• Harsh V, McGarvey EL, Clayton AH. Physician attitudes regarding hypoactive sexual desire disorder in a primary care clinic: a pilot study. J Sex Med. 2008;5(3):640–645.
   PubMed Web of Science ®Google Scholar
• Addyi. Addyi (flibanserin) prescribing information. Raleigh, NC: Sprout Pharmaceuticals Inc.; 2018.
   Google Scholar
• Vyleesi. Vyleesi (bremelanotide) prescribing information. Waltham, MA: AMAG Pharmaceuticals Inc.; 2019.
   Google Scholar
• Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120(2):151–157.
   PubMed Web of Science ®Google Scholar
• Bella AJ, Lee JC, Carrier S, et al. CUA practice guidelines for erectile dysfunction. Can Urol Assoc J. 2015;9(1–2):23–29.
   PubMed Web of Science ®Google Scholar
• Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54–61.
   PubMed Web of Science ®Google Scholar
• Goldstein I, Lines C, Pyke R, et al. National differences in patient–clinician communication regarding hypoactive sexual desire disorder. J Sex Med. 2009;6(5):1349–1357. Erratum in: J Sex Med 2009;6(11):3225.
   PubMed Web of Science ®Google Scholar
• Simon JA. Low sexual desire ‒ is it all in her head? Pathophysiology, diagnosis, and treatment of hypoactive sexual desire disorder. Postgrad Med. 2010;122(6):128–136.
   PubMed Web of Science ®Google Scholar
• Mourikis I, Antoniou M, Matsouka E, et al. Anxiety and depression among Greek men with primary erectile dysfunction and premature ejaculation. Ann Gen Psychiatry. 2015;14(1):34.
   PubMed Web of Science ®Google Scholar
• Shapiro D, Stevens D, Stahl SM. Flibanserin – the female Viagra? Int J Psychiatry Clin Pract. 2017;21(4):259–265.
   PubMed Web of Science ®Google Scholar
• Segraves R, Woodard T. Female hypoactive sexual desire disorder: history and current status. J Sex Med. 2006;3(3):408–418.
   PubMed Web of Science ®Google Scholar
• Jutel A. Framing disease: the example of female hypoactive sexual desire disorder. Soc Sci Med. 2010;70(7):1084–1090.
   PubMed Web of Science ®Google Scholar
• Aftab A, Chen C, McBride J. Flibanserin and its discontents. Arch Womens Ment Health. 2017;20(2):243–247.
   PubMed Web of Science ®Google Scholar
• Kingsberg SA, Clayton AH, Pfaus JG. The female sexual response: current models, neurobiological underpinnings and agents currently approved or under investigation for the treatment of hypoactive sexual desire disorder. CNS Drugs. 2015;29(11):915–933.
   PubMed Web of Science ®Google Scholar
• Rosen RC, Connor MK, Miyasato G, et al. Sexual desire problems in women seeking healthcare: a novel study design for ascertaining prevalence of hypoactive sexual desire disorder in clinic-based samples of U.S. women. J Womens Health (Larchmt). 2012;21(5):505–515.
   PubMed Web of Science ®Google Scholar
• US Census Bureau. Age and Sex Composition: 2010. 2010 Census Briefs [Internet]. 2011 [cited 2018 Nov 15]. Available from: https://www.census.gov/content/dam/Census/library/publications/2011/dec/c2010br-03.pdf
   Google Scholar
• Clayton AH, Valladares Juarez EM. Female sexual dysfunction. Psychiatr Clin North Am. 2017;40(2):267–284.
   PubMed Web of Science ®Google Scholar
• Parish SJ, Goldstein AT, Goldstein SW, et al. Toward a more evidence-based nosology and nomenclature for female sexual dysfunctions – part II. J Sex Med. 2016;13(12):1888–1906.
   PubMedGoogle Scholar
• Bancroft J, Graham CA, Janssen E, et al. The dual control model: current status and future directions. J Sex Res. 2009;46(2–3):121–142.
   PubMed Web of Science ®Google Scholar
• Bitzer J, Giraldi A, Pfaus J. Sexual desire and hypoactive sexual desire disorder in women. Introduction and overview. Standard operating procedure (SOP Part 1). J Sex Med. 2013;10(1):36–49.
   PubMed Web of Science ®Google Scholar
• Georgiadis JR, Kringelbach ML, Pfaus JG. Sex for fun: a synthesis of human and animal neurobiology. Nat Rev Urol. 2012;9(9):486–498.
   PubMed Web of Science ®Google Scholar
• Pfaus JG. Pathways of sexual desire. J Sex Med. 2009;6(6):1506–1533.
   PubMed Web of Science ®Google Scholar
• Stahl SM. Targeting circuits of sexual desire as a treatment strategy for hypoactive sexual desire disorder. J Clin Psychiatry. 2010;71(07):821–822.
   PubMedGoogle Scholar
• Kingsberg SA. Prevalence of hypoactive sexual desire disorder in postmenopausal women: results from the WISHeS Trial. Menopause. 2006;13(1):10–11.
   PubMed Web of Science ®Google Scholar
• Lue TF. Erectile dysfunction. N Engl J Med. 2000;342(24):1802–1813.
   PubMed Web of Science ®Google Scholar
• Rew KT, Heidelbaugh JJ. Erectile dysfunction. Am Fam Physician. 2016;94(10):820–827.
   PubMed Web of Science ®Google Scholar
• Stahl SM. Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder. CNS Spectr. 2015;20(1):1–6.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Morales M. The brain on drugs: from reward to addiction. Cell. 2015;162(4):712–725.
   PubMed Web of Science ®Google Scholar
• Arnow BA, Millheiser L, Garrett A, et al. Women with hypoactive sexual desire disorder compared to normal females: a functional magnetic resonance imaging study. Neuroscience. 2009;158(2):484–502.
   PubMed Web of Science ®Google Scholar
• Gusnard DA, Akbudak E, Shulman GL, et al. Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function. Proc Natl Acad Sci USA. 2001;98(7):4259–4264.
   PubMed Web of Science ®Google Scholar
• Johnson SC, Baxter LC, Wilder LS, et al. Neural correlates of self-reflection. Brain. 2002;125(8):1808–1814.
   PubMed Web of Science ®Google Scholar
• Bianchi-Demicheli F, Cojan Y, Waber L, et al. Neural bases of hypoactive sexual desire disorder in women: an event-related FMRI study. J Sex Med. 2011;8(9):2546–2559.
   PubMed Web of Science ®Google Scholar
• Woodard TL, Nowak NT, Balon R, et al. Brain activation patterns in women with acquired hypoactive sexual desire disorder and women with normal sexual function: a cross-sectional pilot study. Fertil Steril. 2013;100(4):1068–1076.
   PubMed Web of Science ®Google Scholar
• Holstege G. How the emotional motor system controls the pelvic organs. Sex Med Rev. 2016;4(4):303–328.
   PubMedGoogle Scholar
• Cacioppo S. Neuroimaging of female sexual desire and hypoactive sexual desire disorder. Sex Med Rev. 2017;5(4):434–444.
   PubMed Web of Science ®Google Scholar
• Croft HA. Understanding the role of serotonin in female hypoactive sexual desire disorder and treatment options. J Sex Med. 2017;14(12):1575–1584.
   PubMed Web of Science ®Google Scholar
• Kingsberg SA, Althof S, Simon JA, et al. Female sexual dysfunction – medical and psychological treatments, Committee 14. J Sex Med. 2017;14(12):1463–1491. Erratum in: J Sex Med 2018;15(2):270.
   PubMed Web of Science ®Google Scholar
• Jin C, Guan M, Dong M, et al. Aberrant baseline brain activity in psychogenic erectile dysfunction patients: a resting state fMRI study. Brain Imaging Behav. 2018;12(5):1393–1404.
   PubMed Web of Science ®Google Scholar
• Masters WH, Johnson VE. The sexual response cycle of the human female. III. The clitoris: anatomic and clinical consideration. West J Surg Obstet Gynecol. 1962;70:248–257.
   PubMedGoogle Scholar
• Clayton AH. The pathophysiology of hypoactive sexual desire disorder in women. Int J Gynaecol Obstet. 2010;110(1):7–11.
   PubMed Web of Science ®Google Scholar
• Kaplan HS. Hypoactive sexual desire. J Sex Marital Ther. 1977;3(1):3–9.
   PubMed Web of Science ®Google Scholar
• Lief HI. Inhibited sexual desire. Med Aspects Human Sexual. 1977;7:94–95.
   Google Scholar
• Basson R. Women’s sexual dysfunction: revised and expanded definitions. CMAJ. 2005;172(10):1327–1333.
   PubMed Web of Science ®Google Scholar
• O’Loughlin JI, Basson R, Brotto LA. Women with hypoactive sexual desire disorder versus sexual interest/arousal disorder: an empirical test of raising the bar. J Sex Res. 2018;55(6):734–746.
   PubMed Web of Science ®Google Scholar
• Basson R. Female sexual response: the role of drugs in the management of sexual dysfunction. Obstet Gynecol. 98(2):350–353. Erratum in: Obstet Gynecol 2001;98(3):522.
   PubMed Web of Science ®Google Scholar
• Mark K, Herbenick D, Fortenberry D, et al. The object of sexual desire: examining the ‘what’ in ‘what do you desire’? J Sex Med. 2014;11(11):2709–2719.
   PubMed Web of Science ®Google Scholar
• Huri HZM, Sanusi ND, Razack AH, et al. Association of psychological factors, patients’ knowledge, and management among patients with erectile dysfunction. Patient Prefer Adher. 2016;10:807–823.
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhang Y, Wang J, et al. Erectile dysfunction and depression: a systematic review and meta-analysis. J Sex Med. 2018;15(8):1073–1082.
   PubMed Web of Science ®Google Scholar
• Nguyen HMT, Gabrielson AT, Hellstrom W. Erectile dysfunction in young men – a review of the prevalence and risk factors. Sex Med Rev. 2017;5(4):508–520.
   PubMed Web of Science ®Google Scholar
• Rosen RC, Heiman JR, Long JS, et al. Men with sexual problems and their partners: findings from the International Survey of Relationships. Arch Sex Behav. 2016;45(1):159–173.
   PubMed Web of Science ®Google Scholar
• Biddle AK, West SL, D’Aloisio AA, et al. Hypoactive sexual desire disorder in postmenopausal women: quality of life and health burden. Value Health. 2009;12(5):763–772.
   PubMed Web of Science ®Google Scholar
• McCabe MP, Althof SE. A systematic review of the psychosocial outcomes associated with erectile dysfunction: does the impact of erectile dysfunction extend beyond a man’s inability to have sex? J Sex Med. 2014;11(2):347–363.
   PubMed Web of Science ®Google Scholar
• Clayton AH, Maserejian NN, Connor MK, et al. Depression in premenopausal women with HSDD: baseline findings from the HSDD Registry for Women. Psychosom Med. 2012;74(3):305–311.
   PubMed Web of Science ®Google Scholar
• Atlantis E, Sullivan T. Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis. J Sex Med. 2012;9(6):1497–1507.
   PubMed Web of Science ®Google Scholar
• Polland A, Davis M, Zeymo A, et al. Comparison of correlated comorbidities in male and female sexual dysfunction: findings from the Third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). J Sex Med. 2018;15(5):678–686.
   PubMed Web of Science ®Google Scholar
• Zaider T, Manne S, Nelson C, et al. Loss of masculine identity, marital affection, and sexual bother in men with localized prostate cancer. J Sex Med. 2012;9(10):2724–2732.
   PubMed Web of Science ®Google Scholar
• Chambers SK, Chung E, Wittert G, et al. Erectile dysfunction, masculinity, and psychosocial outcomes: a review of the experiences of men after prostate cancer treatment. Transl Androl Urol. 2017;6(1):60–68.
   PubMed Web of Science ®Google Scholar
• Keating GM, Scott LJ. Vardenafil: a review of its use in erectile dysfunction. Drugs. 2003;63(23):2673–2703.
   PubMed Web of Science ®Google Scholar
• Seftel AD, Buvat J, Althof SE, et al. Improvements in confidence, sexual relationship and satisfaction measures: results of a randomized trial of tadalafil 5 mg taken once daily. Int J Impot Res. 2009;21(4):240–248.
   PubMed Web of Science ®Google Scholar
• Althof SE, Buvat J, Gutkin SW, et al. Sexual satisfaction in men with erectile dysfunction: correlates and potential predictors. J Sex Med. 2010;7(1):203–215.
   PubMed Web of Science ®Google Scholar
• Swindle RW, Cameron AE, Lockhart DC, et al. The psychological and interpersonal relationship scales: assessing psychological and relationship outcomes associated with erectile dysfunction and its treatment. Arch Sex Behav. 2004;33(1):19–30.
   PubMed Web of Science ®Google Scholar
• Swindle R, Cameron A, Rosen R. A 15-item short form of the psychological and interpersonal relationship scales. Int J Impot Res. 2006;18(1):82–88.
   PubMed Web of Science ®Google Scholar
• Cappelleri JC, Althof SE, Siegel RL, et al. Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction. Int J Impot Res. 2004;16(1):30–38.
   PubMed Web of Science ®Google Scholar
• DiBenedetti DB, Gondek K, Sagnier PP, et al. The treatment satisfaction scale: a multidimensional instrument for the assessment of treatment satisfaction for erectile dysfunction patients and their partners. Eur Urol. 2005;48(3):503–511.
   PubMed Web of Science ®Google Scholar
• Wincze J, Rosen R, Carson C, et al. Erection quality scale: initial scale development and validation. Urology. 2004;64(2):351–356.
   PubMed Web of Science ®Google Scholar
• Mulhall JP, Goldstein I, Bushmakin AG, et al. Validation of the erection hardness score. J Sex Med. 2007;4(6):1626–1634.
   PubMed Web of Science ®Google Scholar
• Kingsberg SA. Attitudinal survey of women living with low sexual desire. J Womens Health (Larchmt). 2014;23(10):817–823.
   PubMed Web of Science ®Google Scholar
• Pyke R, Clayton A. What sexual behaviors relate to decreased sexual desire in women? A review and proposal for end points in treatment trials for hypoactive sexual desire disorder. Sex Med. 2017;5(2):e73–e83.
   PubMed Web of Science ®Google Scholar
• Pyke RE, Clayton AH. Assessment of sexual desire for clinical trials of women with hypoactive sexual desire disorder: measures, desire-related behavior, and assessment of clinical significance. Sex Med Rev. 2018;6(3):367–383.
   PubMed Web of Science ®Google Scholar
• Kingsberg SA, Rezaee RL. Hypoactive sexual desire in women. Menopause. 2013;20(12):1284–1300.
   PubMed Web of Science ®Google Scholar
• Kingsberg SA, Althof SE. Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction. J Sex Med. 2011;8(12):3262–3270.
   PubMed Web of Science ®Google Scholar
• Symonds T, Spino C, Sisson M, et al. Methods to determine the minimum important difference for a sexual event diary used by postmenopausal women with hypoactive sexual desire disorder. J Sex Med. 2007;4(5):1328–1335.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Female Sexual Dysfunction: The Voice of the Patient [Internet]. 2014 [cited 2018 Nov 15]. Available from: https://www.fda.gov/downloads/drugs/newsevents/ucm453718.pdf
   Google Scholar
• Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208.
   PubMed Web of Science ®Google Scholar
• DeRogatis LR, Edelson J, Revicki DA. Reliability and validity of the Female Sexual Distress Scale–Desire/Arousal/Orgasm instrument in a phase 2B dose-ranging study of bremelanotide. Poster NR8-160 presented at: 167th Annual Meeting of the American Psychiatric Association (APA); 2014 May 3–7 [cited 2018 Nov 19]; New York, NY. Available from: https://www.palatin.com/assets/PAL-P4078-APA-DeRogatis-FSDS-DAO-Reliability-and-Validity-Poster-0421-2-1.pdf
   Google Scholar
• Goldhammer DL, McCabe MP. Development and psychometric properties of the Female Sexual Desire Questionnaire (FSDQ). J Sex Med. 2011;8(9):2512–2521.
   PubMed Web of Science ®Google Scholar
• Revicki DA, Althof S, DeRogatis L, et al. Reliability and validity of the Elements of Desire Questionnaire in the bremelanotide RECONNECT study. [ISSWSH abstract 039]. J Sex Med. 2017;14(6):e364–e365.
   Web of Science ®Google Scholar
• Revicki D, Althof S, DeRogatis L, et al. Elements of desire questionnaire assessment of bremelanotide efficacy for hypoactive sexual desire disorder in the RECONNECT study. [ISSWSH abstract 002]. J Sex Med. 2018;15(6):S99.
   Web of Science ®Google Scholar
• Revicki DA, Clayton AH, Stouch BC, et al. Developing clinically meaningful responder thresholds for primary endpoints for clinical trials in premenopausal women with hypoactive sexual desire disorder. Poster presented at: 14th Annual Scientific Meeting of the International Society for CNS Clinical Trials and Methodology (ISCTM); 2018 Feb 20–22 [cited 2018 Nov 19]; Washington, DC. Available from: https://isctm.org/public_access/Feb2018/PDFs/Revicki-poster.pdf
   Google Scholar
• Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry. 2000;57(11):1012–1030.
   PubMed Web of Science ®Google Scholar
• Seidman SN. Exploring the relationship between depression and erectile dysfunction in aging men. J Clin Psychiatry. 2002;63(Suppl 5):5–12. discussion 23–25.
   PubMed Web of Science ®Google Scholar
• Jayne CJ, Heard MJ, Zubair S, et al. New developments in the treatment of hypoactive sexual desire disorder – a focus on flibanserin. Int J Womens Health. 2017;9:171–178.
   PubMed Web of Science ®Google Scholar